GlassScriptPhysician profile
Alex Horchak
NPI 1033158209
$8,273.59
in general payments reported to CMS, 2019-2025
20 companies · $539 in 2025
The $539 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,217 · 2020: $1,287 · 2021: $1,577 · 2022: $1,522 · 2023: $617 · 2024: $515 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,625.12 | 2019-2020 | |
| Axonics, INC. | $1,573.43 | 2020-2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $933.30 | 2019-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $827.56 | 2019-2025 | |
| Coloplast Corp | $777.78 | 2019-2025 | |
| Boston Scientific Corporation | $699.17 | 2019-2025 | Axonics |
| Janssen Biotech, INC. | $651.53 | 2019-2025 | Erleada, Akeega, Balversa |
| Teleflex LLC | $421.99 | 2021-2025 | Urolift |
| Tolmar, INC. | $182.22 | 2023-2025 | Eligard |
| Abbvie INC. | $139.36 | 2019-2025 | |
| 180 Medical, INC. | $77.78 | 2023-2024 | Gentlecath |
| Isoray, INC | $66.68 | 2019 | |
| Sumitomo Pharma America, INC. | $64.36 | 2023-2024 | Gemtesa |
| Urogen Pharma, INC. | $52.73 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $41.58 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $38.74 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $36.85 | 2025 | |
| Caldera Medical, INC | $29.11 | 2025 | |
| Laborie Medical Technologies Corp. | $18.10 | 2024 | Endosheath Technology |
| Novartis Pharmaceuticals Corporation | $16.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Horchak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.